These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7674361)

  • 1. Panel B wrap-up: strategies for enhancing research and research training programs for African Americans: viewing barriers as opportunities.
    Curry C
    J Natl Med Assoc; 1995 Aug; 87(8 Suppl):632-3. PubMed ID: 7674361
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonists in African-American patients.
    Jamerson K
    Ethn Dis; 1998; 8(1):120-3. PubMed ID: 9595256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panel A wrap-up: concepts, considerations, and challenges in managing hypertension in African-American patients.
    Gifford RW
    J Natl Med Assoc; 1995 Aug; 87(8 Suppl):622-3. PubMed ID: 7674357
    [No Abstract]   [Full Text] [Related]  

  • 4. African-American ethnicity in epidemiological studies of calcium antagonists in relation to cancer.
    Zhu K; Daling JR; Pahor M
    Ethn Dis; 2002; 12(1):144-8. PubMed ID: 11913603
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks.
    Hall WD; Reed JW; Flack JM; Yunis C; Preisser J
    Arch Intern Med; 1998 Oct; 158(18):2029-34. PubMed ID: 9778203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers in black patients with angina pectoris.
    Curry CL; Diggs JA
    J Natl Med Assoc; 1988 May; 80(5):503. PubMed ID: 3418732
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies for enhancing research and research training programs for African Americans: viewing barriers as opportunities.
    Curry C
    J Health Care Poor Underserved; 1997 Aug; 8(3):318-21. PubMed ID: 9253224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronotherapeutic oral drug absorption system verapamil is effective in reducing morning blood pressure in African Americans: a post hoc analysis of the chrono trial.
    Prisant LM; Weber M; Black HR
    J Natl Med Assoc; 2005 Mar; 97(3):377-83. PubMed ID: 15779502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular calcium and sodium regulation, salt-sensitivity and essential hypertension in African Americans.
    Aviv A
    Ethn Health; 1996 Sep; 1(3):275-81. PubMed ID: 9395572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic considerations in the treatment of the black hypertensive.
    Weinberger MH
    Clin Cardiol; 1989 Dec; 12(12 Suppl 4):IV82-6. PubMed ID: 2695276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panel A wrap-up: concepts, considerations, and challenges in managing hypertension in African-American patients.
    Randall OS
    J Natl Med Assoc; 1995 Aug; 87(8 Suppl):618-21. PubMed ID: 7674356
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
    Toto RD
    Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers: their pharmacologic and therapeutic role in hypertension.
    Weir MR
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():5-15. PubMed ID: 19847947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of meta-analysis in assessing racial differences in the effects of antihypertensive medication.
    Messeri P; Workman S; Saunders C; Francis C
    J Natl Med Assoc; 1997 Jul; 89(7):477-85. PubMed ID: 9220697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrendipine in the treatment of mild to moderate hypertension.
    Moser M; Lunn J; Nash DT; Burris JF; Winer N; Simon G; Vlachakis ND
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1085-9. PubMed ID: 6085372
    [No Abstract]   [Full Text] [Related]  

  • 19. Toward improved antihypertensive therapy with calcium channel blockers.
    DeQuattro V
    Ethn Dis; 1998; 8(1):103-10. PubMed ID: 9595254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
    Kountz DS
    J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.